Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Normal human melanocytes can avoid cell death through multiple pathways.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Drugs that block GSK-3 show promise for treating various diseases.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Promising cancer treatments were found, but the manufacturer closed.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.